Poirson Allen's Insider Trades & SAST Disclosures
Poirson Allen's most recent trade in Cytek BioSciences Inc was a trade of 2,503 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Poirson Allen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 2,503 | 23,368 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 2,503 | 59,810 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 1,878 | 25,048 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 1,878 | 60,713 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 975 | 58,835 | - | 6.0 | 5,879 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 790 | 3,693 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 790 | 57,615 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 732 | 59,981 | - | 6.0 | 4,414 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 308 | 57,307 | - | 6.0 | 1,857 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 2,503 | 56,654 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 2,503 | 25,871 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,878 | 26,926 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,878 | 57,557 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 975 | 55,679 | - | 5.5 | 5,392 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 790 | 4,483 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 790 | 54,459 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 732 | 56,825 | - | 5.5 | 4,048 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 308 | 54,151 | - | 5.5 | 1,703 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,669 | 28,374 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,669 | 53,556 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,252 | 28,804 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,252 | 54,157 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 790 | 5,273 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 790 | 52,195 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 651 | 52,905 | - | 6.0 | 3,880 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 488 | 53,669 | - | 6.0 | 2,908 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 308 | 51,887 | - | 6.0 | 1,836 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 3,338 | 30,043 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 3,338 | 52,356 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.22 per share. | 11 Mar 2024 | 1,301 | 51,055 | - | 7.2 | 9,393 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 44,736 | 44,736 | - | - | Employee Stock Option (right to buy) | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 30,056 | 30,056 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 790 | 49,326 | - | - | Common Stock | |
| Cytek BioSciences Inc | Poirson Allen | SVP BUS. AND CORP. DEV. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 790 | 6,063 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Poirson Allen | SVP BUS. AND CORP. DEV. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.38 per share. | 20 Feb 2024 | 308 | 49,018 | - | 8.4 | 2,581 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 2,503 | 35,884 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 2,503 | 47,501 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 18 Aug 2023 | 975 | 46,526 | - | 8.5 | 8,249 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 790 | 7,643 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 790 | 45,306 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 18 Aug 2023 | 308 | 44,998 | - | 8.5 | 2,606 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,669 | 38,387 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,669 | 44,859 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 790 | 43,498 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 790 | 8,433 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 18 May 2023 | 651 | 44,208 | - | 6.7 | 4,355 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 18 May 2023 | 308 | 43,190 | - | 6.7 | 2,061 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 60,541 | 60,541 | - | - | Employee Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 40,056 | 40,056 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 790 | 43,016 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 790 | 9,223 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.97 per share. | 21 Feb 2023 | 308 | 42,708 | - | 11.0 | 3,379 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 790 | 10,013 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 790 | 42,297 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Bus. and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.75 per share. | 18 Nov 2022 | 308 | 41,989 | - | 14.8 | 4,543 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 1,053 | 41,436 | - | - | Common Stock | |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 1,053 | 11,593 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.65 per share. | 18 May 2022 | 411 | 41,025 | - | 9.6 | 3,966 | Common Stock |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 19,081 | 19,081 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 12,646 | 12,646 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Allen Poirson | SVP Marketing and Corp. Dev. | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 22 Jul 2021 | 1,500 | 40,383 | - | 17 | 25,500 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges